Literature DB >> 9806728

Hemorheological changes in nephrotic syndrome.

S Sahu1, K Nageswari, R Banerjee, R R Puniyani.   

Abstract

Hemorheological parameters of childhood nephrotic syndrome cases, in relapse and remission (n = 60 in each group), were studied and their results were compared with those of an equal number of age and sex matched normal children free from any renal disease. During relapse, it was noticed that the viscosity parameters, viz. plasma viscosity, red cell rigidity and whole blood viscosity, were deranged when compared to the values obtained in the remission period. These observations were statistically analyzed using t-test with the level of significance p = 0.05. It was also noted that serum/plasma biochemistry played an important role with regards to the fluidity of blood. During relapse period, fibrinogen level was significantly high, which persisted at a high level even during remission when compared to normal controls. The high cholesterol and triglyceride levels during relapse were responsible for a high plasma viscosity, increased red cell rigidity and thereby contributed directly to a marked increase in whole blood viscosity. Total protein and albumin levels were significantly decreased during relapse when compared to remission period. Hence, hemorheological parameters can be used for early detection of cases prone to relapse and could be of prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806728

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  2 in total

1.  Tissue factor pathway inhibitor in childhood nephrotic syndrome.

Authors:  Mohamed M Al-Mugeiren; Abdel Galil M Abdel Gader; Saud A Al-Rasheed; Abdullah A Al-Salloum
Journal:  Pediatr Nephrol       Date:  2006-03-31       Impact factor: 3.714

2.  Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats.

Authors:  Hua-Ying Fan; Ming-Yan Yang; Dong Qi; Zuo-Kai Zhang; Lin Zhu; Xiu-Xin Shang-Guan; Ke Liu; Hui Xu; Xin Che
Journal:  Sci Rep       Date:  2015-07-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.